HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
CLDN5
claudin 5
Chromosome 22 Β· 22q11.21
NCBI Gene: 7122Ensembl: ENSG00000184113.10HGNC: HGNC:2047UniProt: D3DX19
143PubMed Papers
20Diseases
0Drugs
6Pathogenic Variants
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
apicolateral plasma membraneprotein bindingnegative regulation of vascular permeabilitycortical actin cytoskeletongenetic disorderepilepsyIntellectual disabilityNeurodevelopmental disorder
✦AI Summary

CLDN5 encodes claudin-5, a critical tight junction protein that maintains blood-brain barrier (BBB) integrity by limiting passive diffusion of ions and solutes across brain microvascular endothelial cells 1. The protein's expression is tightly regulated by other junctional proteins, pericytes, and astrocytes 1. CLDN5 functions through multiple mechanisms including regulation by epigenetic factors like HDAC1 and EZH2, which control its transcriptional expression 23. Under pathological conditions, CLDN5 can be redistributed from cell membranes to cytoplasm via CAV1-mediated mechanisms, where autophagy helps degrade aggregated protein to protect BBB integrity 4. Disease relevance is significant, as compromised BBB function due to CLDN5 decline increases risks of neuropsychiatric disorders, epilepsy, and dementia 1. Loss of CLDN5 allows peripheral inflammatory cytokines like TNF-Ξ± to infiltrate the brain, contributing to depression-like behaviors 23. Microglia play a dual role in BBB maintenance by initially expressing CLDN5 to maintain barrier function, but later phagocytosing astrocytic end-feet during sustained inflammation 5. Beyond CNS disorders, CLDN5 also plays roles in tumor growth, metastasis, and various non-neurological diseases 67.

Sources cited
1
CLDN5 encodes claudin-5 that forms tight junctions limiting passive diffusion and is regulated by other proteins and support cells
PMID: 36978081
2
CLDN5 loss allows inflammatory cytokine passage and depression-like behaviors, regulated by epigenetic factors like HDAC1
PMID: 31974313
3
Autophagy protects BBB by degrading cytoplasmic CLDN5 aggregates formed through CAV1-mediated redistribution
PMID: 33280500
4
EZH2-mediated epigenetic regulation of CLDN5 controls BBB dysfunction and TNF-Ξ± infiltration in depression
PMID: 37848095
5
Microglia maintain BBB integrity via CLDN5 expression but later impair function during sustained inflammation
PMID: 31862977
6
CLDN5 plays roles in tumors and diseases beyond CNS disorders
PMID: 38228255
7
CLDN5 identified as pivotal gene in osteoarthritis through bioinformatics analysis
PMID: 39906135
Disease Associationsβ“˜20
genetic disorderOpen Targets
0.41Moderate
epilepsyOpen Targets
0.37Weak
Intellectual disabilityOpen Targets
0.37Weak
Neurodevelopmental disorderOpen Targets
0.34Weak
hypotensionOpen Targets
0.30Weak
placental retentionOpen Targets
0.16Weak
osteoarthritis, hipOpen Targets
0.14Weak
Neurodevelopmental abnormalityOpen Targets
0.11Weak
urinary system diseaseOpen Targets
0.10Weak
neoplasmOpen Targets
0.09Suggestive
schizophreniaOpen Targets
0.09Suggestive
breast cancerOpen Targets
0.08Suggestive
Alzheimer diseaseOpen Targets
0.08Suggestive
cancerOpen Targets
0.08Suggestive
chronic obstructive pulmonary diseaseOpen Targets
0.08Suggestive
heart diseaseOpen Targets
0.08Suggestive
strokeOpen Targets
0.07Suggestive
coronary artery diseaseOpen Targets
0.07Suggestive
AnxietyOpen Targets
0.07Suggestive
COVID-19Open Targets
0.06Suggestive
Pathogenic Variants6
NM_001363066.2(CLDN5):c.178G>A (p.Gly60Arg)Pathogenic
CLDN5-related neurodevelopmental disorder|Inborn genetic diseases|Syndromic disease
β˜…β˜…β˜†β˜†2025β†’ Residue 60
NM_001363066.2(CLDN5):c.121G>A (p.Val41Met)Pathogenic
not provided|Neurodevelopmental disorder
β˜…β˜…β˜†β˜†2023β†’ Residue 41
NM_001363066.2(CLDN5):c.187C>A (p.Gln63Lys)Likely pathogenic
CLDN5-related hemiplegia, microcephaly and brain calcification
β˜…β˜†β˜†β˜†2025β†’ Residue 63
NM_001363066.2(CLDN5):c.174C>G (p.Ser58Arg)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 58
NM_001363066.2(CLDN5):c.176C>T (p.Thr59Ile)Pathogenic
CLDN5 deficiency
β˜…β˜†β˜†β˜†2024β†’ Residue 59
NM_001363066.2(CLDN5):c.175_177dup (p.Thr59_Gly60insThr)Likely pathogenic
CLDN5-related neurodevelopmental disorder
β˜…β˜†β˜†β˜†2024β†’ Residue 59
View on ClinVar β†—
Related Genes
CBFBProtein interaction100%F11RProtein interaction99%CAV1Protein interaction97%OCLNProtein interaction95%VWFProtein interaction92%TJP2Protein interaction92%
Tissue Expression6 tissues
Lung
100%
Brain
18%
Ovary
11%
Liver
7%
Heart
6%
Bone Marrow
1%
Gene Interaction Network
Click a node to explore
CLDN5CBFBF11RCAV1OCLNVWFTJP2
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt O00501
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
1.97LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF2.95 [1.03–1.97]
RankingsWhere CLDN5 stands among ~20K protein-coding genes
  • #3,191of 20,598
    Most Researched143 Β· top quartile
  • #3,331of 5,498
    Most Pathogenic Variants6
  • #17,795of 17,882
    Most Constrained (LOEUF)1.97
Genes detectedCLDN5
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
The CLDN5 gene at the blood-brain barrier in health and disease.
PMID: 36978081
Fluids Barriers CNS Β· 2023
1.00
2
Molecular adaptations of the blood-brain barrier promote stress resilience vs. depression.
PMID: 31974313
Proc Natl Acad Sci U S A Β· 2020
0.90
3
Autophagy alleviates hypoxia-induced blood-brain barrier injury via regulation of CLDN5 (claudin 5).
PMID: 33280500
Autophagy Β· 2021
0.80
4
Spatial Transcriptomic Characteristics of the Aging Human Ovary.
PMID: 41243550
Aging Cell Β· 2026
0.70
5
Identification and Validation of Pivotal Genes in Osteoarthritis Combined with WGCNA Analysis.
PMID: 39906135
J Inflamm Res Β· 2025
0.60